Literature DB >> 15470015

Secreted immunomodulatory viral proteins as novel biotherapeutics.

Alexandra Lucas1, Grant McFadden.   

Abstract

Many viruses have learned to evade or subvert the host antiviral immune responses by encoding and expressing immunomodulatory proteins that protect the virus from attack by elements of the innate and acquired immune systems. Some of these viral anti-immune regulators are expressed as secreted proteins that engage specific host immune targets in the extracellular environment, where they exhibit potent anti-immune properties. We review here viral immunomodulatory proteins that have been tested as anti-inflammatory reagents in animal models of disease caused by excessive inflammation or hyperactivated immune pathways. The potential for such viral molecules for the development of novel drugs to treat immune-based or inflammatory disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470015     DOI: 10.4049/jimmunol.173.8.4765

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Myxoma virus: propagation, purification, quantification, and storage.

Authors:  Sherin E Smallwood; Masmudur M Rahman; Dorothy W Smith; Grant McFadden
Journal:  Curr Protoc Microbiol       Date:  2010-05

2.  The agnoprotein of polyomavirus JC is released by infected cells: evidence for its cellular uptake by uninfected neighboring cells.

Authors:  Onder Otlu; Francesca Isabella De Simone; Yolanda-Lopez Otalora; Kamel Khalili; Ilker Kudret Sariyer
Journal:  Virology       Date:  2014-08-23       Impact factor: 3.616

3.  An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.

Authors:  M Begoña Ruiz-Argüello; Vincent P Smith; Gabriele S V Campanella; Françoise Baleux; Fernando Arenzana-Seisdedos; Andrew D Luster; Antonio Alcami
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

4.  Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor.

Authors:  Olga Y Lubman; Marina Cella; Xinxin Wang; Kristen Monte; Deborah J Lenschow; Yina H Huang; Daved H Fremont
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model.

Authors:  Cari Fritz-French; Ramzi Shawahna; Jennifer E Ward; Leonard E Maroun; William R Tyor
Journal:  J Interferon Cytokine Res       Date:  2014-02-24       Impact factor: 2.607

Review 6.  Viral serpin therapeutics from concept to clinic.

Authors:  Hao Chen; Donghang Zheng; Jennifer Davids; Mee Yong Bartee; Erbin Dai; Liying Liu; Lyubomir Petrov; Colin Macaulay; Robert Thoburn; Eric Sobel; Richard Moyer; Grant McFadden; Alexandra Lucas
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  J Cell Physiol       Date:  2017-08-28       Impact factor: 6.384

8.  Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions.

Authors:  Nathan P Manes; Ryan D Estep; Heather M Mottaz; Ronald J Moore; Therese R W Clauss; Matthew E Monroe; Xiuxia Du; Joshua N Adkins; Scott W Wong; Richard D Smith
Journal:  J Proteome Res       Date:  2008-01-19       Impact factor: 4.466

9.  Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.

Authors:  Elena Domingo-Gil; Eva Pérez-Jiménez; Iván Ventoso; José L Nájera; Mariano Esteban
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.

Authors:  Erbin Dai; Li-Ying Liu; Hao Wang; Dana McIvor; Yun Ming Sun; Colin Macaulay; Elaine King; Ganesh Munuswamy-Ramanujam; Mee Yong Bartee; Jennifer Williams; Jennifer Davids; Israel Charo; Grant McFadden; Jeffrey D Esko; Alexandra R Lucas
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.